CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab.
Saved in:
| Title: | CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab. |
|---|---|
| Authors: | Hsu, Andrew1,2 (AUTHOR), Kurt, Habibe3 (AUTHOR), Zayac, Adam S.1 (AUTHOR), Olszewski, Adam J.1,2 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Jan2022, Vol. 63 Issue 1, p31-42. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 154569789 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hsu%2C+Andrew%22">Hsu, Andrew</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kurt%2C+Habibe%22">Kurt, Habibe</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zayac%2C+Adam+S%2E%22">Zayac, Adam S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Olszewski%2C+Adam+J%2E%22">Olszewski, Adam J.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Jan2022, Vol. 63 Issue 1, p31-42. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=154569789 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2021.1973670 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 31 Titles: – TitleFull: CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hsu, Andrew – PersonEntity: Name: NameFull: Kurt, Habibe – PersonEntity: Name: NameFull: Zayac, Adam S. – PersonEntity: Name: NameFull: Olszewski, Adam J. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 10428194 Numbering: – Type: volume Value: 63 – Type: issue Value: 1 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |